The "China Patent Award" is a national award specifically designed to recognize inventions and creations granted patent rights, and it is recognized by the World Intellectual Property Organization (WIPO) of the United Nations, giving it a certain level of international influence. The selection criteria encompass multiple dimensions, including patent quality, advanced technological level, application and protection measures and outcomes during market commercialization, as well as social and economic benefits. Winning patents not only represent the high standard of national independent scientific and technological innovation but also signify that corporate technology patents have gone global and gained international industry recognition. Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.'s first-time participation and subsequent winning of this award is a high affirmation of the company's R&D capabilities and independent innovation strength.
Breaking international monopolies, leading the industry with research and innovation capabilities
It is reported that internationally, the key excipient for intravenous fat emulsions—injectable egg yolk phosphatidylcholine—due to its complex extraction process and technology, is mastered by only a few foreign companies such as Germany, which have achieved industrial production. However, Baiyunshan Hanfang adheres to R&D principles such as "quality, safety, efficiency, and stability," has overcome numerous critical technical challenges, successfully realized the industrialization and domestic production of injectable egg yolk phosphatidylcholine—a rare achievement in China—thereby breaking the monopoly and accelerating the development of China's fat emulsion field.
This time, Baiyunshan Hanfang's award-winning project further developed a high-purity injectable egg yolk phosphatidylcholine product, once again demonstrating Baiyunshan Hanfang's high-level independent innovation capability.
Technology as the foundation, innovation as the priority, setting an industry benchmark for quality
Baiyunshan Hanfang's winning of the China Patent Excellence Award this time is by no means accidental; it stems from long-term persistence and hard work.
Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., affiliated with Guangzhou Pharmaceutical Group, is a high-tech enterprise specializing in the production of health supplements, special medical purpose formula foods, specialty APIs, high-end pharmaceutical lipid excipients, natural medicines and preparations. It serves as a demonstration base for the industrialization of high-tech traditional Chinese medicine extraction, separation, and purification, and is also the "National Engineering Research Center for the Modernization of Traditional Chinese Medicine Extraction, Separation, and Purification Process" approved for construction by relevant authorities.
Committed to becoming a pioneer enterprise in health nutrition technology and a supplier of specialty API excipients
Throughout its history, Baiyunshan Hanfang has consistently adhered to the development philosophy of "professionalism, technology, and peace of mind," fully leveraging the leading research advantages of the National Engineering Research Center to achieve remarkable accomplishments in technological innovation, intellectual property, and other fields. The company has undertaken more than 80 science and technology projects at national, provincial, and municipal levels, obtained 54 authorized invention patents, published over 200 academic papers and one academic monograph, and received multiple honors such as the National High-Tech Industrialization Demonstration Project, Provincial and Municipal Key Laboratories for Pharmaceutical Lipids, Provincial Independent Innovation Demonstration Enterprise, and Provincial Enterprise Technology Center. Moreover, its related products have obtained EU CEP certification and the company has even led the formulation of international business standards for Ganoderma spore oil, thereby setting an industry benchmark for quality.
Guangzhou Pharmaceutical Ganoderma Spore Oil has won nine invention patents
During Baiyunshan Hanfang's many years of scientific and technological innovation and R&D, Guangzhou Pharmaceutical Ganoderma Spore Oil represents the core product through which Baiyunshan Hanfang inherits the millennial Ganoderma culture, integrates modern scientific and technological innovation with traditional Chinese medicine, and meticulously crafts it. Made from high-quality Ganoderma spore powder, it is produced using patented technology for efficient cell wall breaking and high-ratio extraction and concentration, yielding a highly nutritious Ganoderma spore essence. Its core functional components are highly concentrated, rich in active ingredients such as Ganoderma ergosterol, which can enhance immunity.
Guangzhou Pharmaceutical Ganoderma Spore Oil has obtained nine national invention patents (e.g., ZL200410051412.4), and in July 2018, Baiyunshan Hanfang, backed by strong technological strength, led the formulation of international business standards for Ganoderma spore oil, thus setting the benchmark for industry quality.
